Figure 1.
Kaplan–Meier estimates of progression-free survival according to different treatment groups. The elderly patients in the CRT group had a significantly longer median progression-free survival than that in the RT group, 15.3 versus 10.6 months, P = .008. CRT = chemoradiotherapy, RT = radiotherapy.